Research landscape, thematic evolution, and translational insights of immune checkpoint inhibitor-induced colitis: a bibliometric analysis (2006-2025) - Takeaways - MDSpire

Research landscape, thematic evolution, and translational insights of immune checkpoint inhibitor-induced colitis: a bibliometric analysis (2006-2025)

  • By

  • Huiyong Zheng

  • Chuang Lai

  • Fangteng Liu

  • Hongliang Luo

  • May 18, 2026

  • 0 min

Share

  • 1

    The study analyzed 1,010 papers on immune checkpoint inhibitor-induced colitis from 62 countries, highlighting global research collaboration.

  • 2

    The United States led in publication volume and citations, with the University of Texas MD Anderson Cancer Center being the top contributor.

  • 3

    Wang Yinghong was identified as the most prolific author, while the Journal for Immunotherapy of Cancer was the most published journal in this field.

  • 4

    Key research themes identified include ICI, colitis, immunotherapy, and specific drugs like Ipilimumab and Nivolumab.

  • 5

    Future research should focus on combination therapies, clinical management strategies, and identifying biomarkers for ICI-induced colitis.

Original Source(s)

Research landscape, thematic evolution, and translational insights of immune checkpoint inhibitor-induced colitis: a bibliometric analysis (2006-2025)

  • by Huiyong Zheng, Chuang Lai, Fangteng Liu, Hongliang Luo

  • May 18, 2026

Related Content

VANGL1 links angiogenesis–stemness programs and tumor microenvironment remodeling: a pan-cancer, multi-omics study with translational validation

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2